Streamline workflows with long DNA that does not compromise on accuracy.
Despite significant advancements, the field of Synthetic Biology has yet to fully deliver on its promise of a world where we can overcome the challenges we face in human health and our environment by programming biology itself. To help, the team at Elegen is revolutionizing the field by leveraging high-accuracy gene synthesis to produce a new class of DNA. With an industry-leading combination of length, speed, and accuracy, ENFINIA DNA is set to disrupt the gene synthesis status quo and democratize the agile development of biology.
With ENFINIA DNA, customers can now short-circuit the tedious, slow, and costly build phase without compromising on quality. Instead of relying on short DNA that is less than 3kb in length with error rates higher than 1:5000 bp or waiting weeks for clonal synthesis services, get the long DNA you need now without sacrificing quality. Imagine being able to transition designs to functional testing at lightning-fast speeds, receiving DNA at lengths up to 7kb in just 7 days with an average error rate lower than 1:65000 bp. This is the future of Synthetic Biology, and Elegen is leading the charge with a new class of DNA.
|Elegen Standard Complexity||Elegen High Complexity|
|DNA sequence length||300 - 5.500bp||300 - 7,000bp|
|Overall GC content||25 - 65%||25 - 75%|
|100bp GC content||22 - 75%||16 - 80%|
|Local GC variation||up to 60%||up to 60%|
|Repeats||up to 20bp||up to 100bp|
|Homopolymers*||up to 7 bases for G/C and 8 bases for A/T||up to 10 bases for G/C and 20 bases for A/T|
* At this time, the QC methods we use for production do not provide high confidence in fidelity of A/T homopolymer sequences longer than 10bp. A/T homopolymer sequences up to 20bp will be accepted, but we cannot guarantee synthesis quality above 10bp. We are working to address this in the near future.